Human S9 Fraction Heart

Kosheeka’s Human Heart S9 Fraction is a crucial resource for researchers and scientists engaged in cardiovascular drug metabolism, pharmacokinetics, and cardiac toxicology studies.

+ Product Sheet
+ MSDS
+ PI

General Description

Kosheeka’s Human Heart S9 Fraction is a crucial resource for researchers and scientists engaged in cardiovascular drug metabolism, pharmacokinetics, and cardiac toxicology studies. Derived from human heart tissue, this S9 fraction contains a rich concentration of drug-metabolizing enzymes and cardiac-specific proteins, making it an invaluable tool for in vitro investigations of drug metabolism within the heart. With meticulous purification and quality control processes, our Human Heart S9 Fraction ensures reliability and consistency in your research, enabling a deeper understanding of cardiac drug interactions, metabolism, and safety evaluations. This product provides an authentic and physiologically relevant platform for studying cardiac-specific pharmacology and advancing cardiovascular drug development.